Searched for
ACTEMRA
Dr Reddy's Laboratories jumps into the fray for Biogen's biosimilarsDr Reddy's Laboratories (DRL) and Intas Pharmaceuticals, both Indian companies, are reportedly in the race to acquire the biosimilar produc...- EU assesses Regeneron/Roche COVID-19 antibody cocktail for authorisationTill now, only Gilead's antiviral, remdesivir, is the only COVID-19 treatment that has been approved for use in EU. Japanese regulators app...
- US approves Roche drug for emergency use against severe Covid-19Though rising vaccinations in places such as Europe and the United States are reducing hospitalizations for COVID-19, Actemra is still bein...
- Roche to boost Tocilizumab supply to meet rising demand in IndiaThe cost of the drug in India is upwards of ₹50,000 per vial. However, due to shortage the drug has been selling at exorbitant prices accor...
- Gilead donates remdesivir vials to govt to make up for delays on part of its partnersUS drugmaker Gilead Sciences on Tuesday donated 450,000 vials of the Covid-19 drug remdesivir to India, even as the delayed supplies from i...
- Novartis agrees to make ingredients Roche's Actemra for COVID-19 patientsThe arrangement is the third transaction signed by Novartis following agreements with BioNTech and CureVac to make therapies for other firm...
- 120-165% rally not enough for these 7 Nifty stocks: Analysts say ‘Yeh Dil Maange More’Among three stocks that gained over 150 per cent from the March-April lows, IndusInd Bank has soared 164.2 per cent to Rs 622.45 from Rs 23...
- Government looks to review Tocilizumab inclusion for treatment, againTocilizumab,a rheumatoid arthritis drug, is part of the health ministry’s clinical management protocol for Covid-19 under investigational t...
- ICMR reviewing use of tocilizumab for treatment of coronavirus pandemicTocilizumab is a rheumatoid arthritis drug manufactured by Swiss pharmaceutical company Roche under the brand name Actemra. The medication ...
- Roche Pharma India expands partnership with Cipla for key oncology medicinesRoche Pharma India has signed a "distribution agreement with Cipla to expand the scope of the partnership to include, marketing and distrib...
- Dilemma for doctors as Roche’s experimental drug for Covid-19 is ‘life-saver’ but too costlyIn India, the drug sold under the brand name Actemra, is approved for the use in autoimmune disease such as rheumatoid arthritis and for si...
- Coronavirus medicine: An arthritis drug could be the answer everyone is looking forThe Chinese government approved Swiss drugmaker Roche's anti-inflammation drug Actemra to treat severe coronavirus symptoms. This comes at ...
- Cipla's U-turn: Happily ever after?In a foes-turn-friends move announced on February 27, the Mumbai-based drug maker announced that it will partner Swiss biotech company Roch...
- Roche and Cipla tie up to market anti cancer drugsRoche said this partnership will also enable it to focus on bringing new, transformative medicines to patients in India.
- Roche passes on Budget gain, cuts life-saving drug pricesLess than a month after duty cuts on life-saving drugs were announced in the Budget, Swiss pharma giant Roche took the first step in passin...
Load More
